Covance | ULTIMATE |

(often sold as Covance CP or Covance 50) is a brand name for the prescription drug Losartan . Primary Uses: Treats high blood pressure (hypertension).

Assisting companies with FDA filings and drug commercialization.

Formerly known as Covance Inc., this company is a major Contract Research Organization (CRO) that manages clinical trials and laboratory testing. COVANCE

The name can refer to two very different things: a global drug development company (now rebranded) or a blood pressure medication . 1. Covance (The Company)

It is an Angiotensin II Receptor Blocker (ARB) that relaxes blood vessels to lower pressure and ease heart strain. (often sold as Covance CP or Covance 50)

Managing phases I–IV of drug development for pharmaceutical and biotech firms.

Operating central laboratories for specimen testing and medical device verification. Formerly known as Covance Inc

Covance was acquired by Labcorp in 2015 and officially rebranded as Labcorp Drug Development in 2021. In 2023, the clinical development portion was spun off as an independent company named Fortrea . Key Services: